1. Home
  2. NTST vs NVAX Comparison

NTST vs NVAX Comparison

Compare NTST & NVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NTST
  • NVAX
  • Stock Information
  • Founded
  • NTST 2019
  • NVAX 1987
  • Country
  • NTST United States
  • NVAX United States
  • Employees
  • NTST N/A
  • NVAX N/A
  • Industry
  • NTST Real Estate Investment Trusts
  • NVAX Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • NTST Real Estate
  • NVAX Health Care
  • Exchange
  • NTST Nasdaq
  • NVAX Nasdaq
  • Market Cap
  • NTST 1.3B
  • NVAX 1.3B
  • IPO Year
  • NTST 2020
  • NVAX 1995
  • Fundamental
  • Price
  • NTST $16.10
  • NVAX $7.34
  • Analyst Decision
  • NTST Strong Buy
  • NVAX Buy
  • Analyst Count
  • NTST 8
  • NVAX 5
  • Target Price
  • NTST $18.16
  • NVAX $19.00
  • AVG Volume (30 Days)
  • NTST 787.9K
  • NVAX 14.2M
  • Earning Date
  • NTST 07-28-2025
  • NVAX 05-08-2025
  • Dividend Yield
  • NTST 5.22%
  • NVAX N/A
  • EPS Growth
  • NTST N/A
  • NVAX N/A
  • EPS
  • NTST N/A
  • NVAX 2.97
  • Revenue
  • NTST $171,021,000.00
  • NVAX $1,254,962,000.00
  • Revenue This Year
  • NTST $12.47
  • NVAX $40.01
  • Revenue Next Year
  • NTST $6.96
  • NVAX N/A
  • P/E Ratio
  • NTST N/A
  • NVAX $2.47
  • Revenue Growth
  • NTST 22.05
  • NVAX 25.92
  • 52 Week Low
  • NTST $13.42
  • NVAX $5.01
  • 52 Week High
  • NTST $17.53
  • NVAX $23.86
  • Technical
  • Relative Strength Index (RSI)
  • NTST 56.10
  • NVAX 55.86
  • Support Level
  • NTST $15.37
  • NVAX $6.84
  • Resistance Level
  • NTST $16.18
  • NVAX $7.62
  • Average True Range (ATR)
  • NTST 0.31
  • NVAX 0.55
  • MACD
  • NTST 0.01
  • NVAX 0.07
  • Stochastic Oscillator
  • NTST 91.53
  • NVAX 50.52

About NTST NetSTREIT Corp.

Netstreit Corp is an internally managed real estate investment trust. The company acquires, owns, and manages single-tenant, retail commercial real estate subject to long-term net leases with high-credit quality tenants across the United States. It focuses on tenants in industries where a physical location is critical to the generation of sales and profits, with a focus on necessity goods and essential services in the retail sector, including home improvement, auto parts, drug stores and pharmacies, general retail, grocers, convenience stores, discount stores, and quick-service restaurants. Majorily operates in U.S. States and Other counties, and derives maximum of revenue from USA.

About NVAX Novavax Inc.

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. It works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. The company manages its business as one operating segment, the development and commercialization of vaccines. The company generates maximum revenue from the United States.

Share on Social Networks: